OTC - ACTIVE INGREDIENT SECTION
Ammonium Carbonate 15%
Ammonium Carbonate 15%
Inhalant
Uses: To prevent or treat fainting.
FOR EXTERNAL USE ONLY.
Avoid contact with skin or eyes. Rinse immediately
with water for 15 minutes if exposed, Flammable.
Keep away from heat, flames, or sparks. For emergency
use only, Not a substitute for professional medical care.
Individuals with asthma or chronic respiratory conditions.
Children under 2 years of age.
Do not use if you are pregnant or nursing.
Do not use if you have or are being treated for anymedical condition.
Avoid repeated inhalation. Do not use more than 2 times
per application.
OTC-Keep out of reach of children. Store in a cool (15-25°C) dark, and dry place inaccessible to children. Swallowing may cause poisoning.
If you experience any adverse reaction, discontinue useimmediately and consult a healthcare professional.
1.Hold bottle 10-15 cm from nostrils and inhale slowty 1-2 times.
2.Seal tightly after each use to prevent prolonged exposure.
Cotton
Peppermint Flavour
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 87055-001-01 | Smelling Salt | 30 g in 1 BOTTLE | INHALANT | 30 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 87055-001 | 87055-001-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| AMMONIUM CARBONATE | NJ5VT0FKLJ | ACTIB |
| COTTON | 70LDW53ROO | IACT |
| PEPPERMINT | V95R5KMY2B | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 3ceb42f7-d42d-9477-e063-6294a90a8e7d | 3ceb42f7-d42c-9477-e063-6294a90a8e7d | 2025-08-21 | Warnings | 3ceb42f7-d42d-9477-e063-6294a90a8e7d 3ceb42f7-d42c-9477-e063-6294a90a8e7d |
Adverse event summaries are temporarily unavailable. Other product information remains available.